Compound ID | 1738
AR-101
Synonym(s): AerumabTM | Panobacumab
Class: Antibody (monoclonal antibody [mAb])
| Spectrum of activity: | Gram-negative |
| Details of activity: | Active against P. aeruginosa |
| Institute where first reported: | Aimmune Therapeutics |
| Year first mentioned: | 2020 |
| Highest developmental phase: | Phase 3 |
| External links: | |
| Guide to Pharmacology: | panobacumab |
| Main Source: | https://www.nature.com/articles/s41429-020-0344-z |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us.
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.